©istock.com/Andrea Obzerova
Interdisciplinary CompetenceMolecular Diagnostics
Know how in the analysis of genetic material.
For the benefit of patients.

IllnessPrenatal akinesia / hypokinesia, differential diagnosis

Summary

Short information

Comprehensive differential diagnostic panel for Prenatal akinesia / hypokinesia containing 12 core candidate genes and altogether 67 curated genes according to the clinical signs

ID
PP3647
Number of genes
43 Accredited laboratory test
Examined sequence length
24,1 kb (Core-/Core-canditate-Genes)
237,0 kb (Extended panel: incl. additional genes)
Analysis Duration
on request
Test material
  • Amniotic fluid (after amnocentesis)
  • Chorionic villus
  • Umbilical cord blood
Diagnostic indications

NGS +

 

Gene panel

Selected genes

NameExon Length (bp)OMIM-GReferenz-Seq.Heredity
ASCC11074NM_001198800.3AR
BICD22568NM_001003800.2AR
CHRNA11374NM_000079.4AD, AR
CHRND1554NM_000751.3AR
CHRNG1554NM_005199.5AR
CNTN13057NM_001843.4AR
DOK71515NM_173660.5AR
ERCC64482NM_000124.4AR
GBE12109NM_000158.4AR
MUSK2610NM_005592.4AR
MYOD1963NM_002478.5AR
RAPSN1239NM_005055.5AR
CACNA1S5622NM_000069.3AD, AR
CNTNAP14155NM_003632.3AR
DMPK1920NM_001081563.2AD
DNM22613NM_001005360.3AR, AD
ECEL12328NM_004826.4AR
ERCC1972NM_202001.3AR
ERCC22283NM_000400.4AR
ERCC32349NM_000122.2AR
FKTN1386NM_001079802.2AR
GLE12097NM_001003722.2AR
HRAS570NM_005343.4AD
IRF61404NM_006147.4AD
LGI41614NM_139284.3AR
LMNA1995NM_170707.4AD, AR
MAGEL23750NM_019066.5AD
MYBPC13516NM_002465.4AD, AR
MYH35823NM_002470.4AD
MYH85814NM_002472.3AD
NUP882291NM_002532.6AR
PIEZO28259NM_022068.4AD, AR
RIPK42355NM_020639.3AR
RYR115117NM_000540.3AD, AR
SMN1885NM_000344.4AR
SYNE126250NM_033071.4AR
TNNI2549NM_003282.4AD
TPM2855NM_003289.4AD
TRIP41759NM_016213.5AR
TTN100272NM_001267550.2AR
VIPAS391482NM_022067.4AR
VPS33B1854NM_018668.5AR
ZC4H2675NM_018684.4XL

Informations about the disease

Clinical Comment

Multiple joint contractures, facial anomalies, pulmonary hypoplasia. Common feature is decreased foetal activity

 

Synonyms
  • Alias: Fetal akinesia deformation sequence
  • Alias: Prenatal akiesia/hypokinesia
  • Allelic: Barrett esophagus/esophageal adenocarcinoma (ASCC1)
  • Allelic: CAP myopathy 2 (TPM2)
  • Allelic: CHAND syndrome (RIPK4)
  • Allelic: Cardiomyopathy, dilated, 1G (TTN)
  • Allelic: Cardiomyopathy, familial hypertrophic, 9 (TTN)
  • Allelic: Cockayne syndrome, type B (ERCC6)
  • Allelic: Costello syndrome (HRAS)
  • Allelic: De Sanctis-Cacchione syndrome (ERCC6)
  • Allelic: Emery-Dreifuss muscular dystrophy 4, AD (SYNE1)
  • Allelic: Erythroleukemia, familial, susceptibility to (ERBB3)
  • Allelic: Fibrosis of extraocular muscles, congenital, 1 (KIF21A)
  • Allelic: Fibrosis of extraocular muscles, congenital, 3B (KIF21A)
  • Allelic: Heart-hand syndrome, Slovenian type (LMNA)
  • Allelic: Hutchinson-Gilford progeria (LMNA)
  • Allelic: Intellectual developmental disorder, AD 56 (CLTC)
  • Allelic: Lipodystrophy, familial partial, type 2 (LMNA)
  • Allelic: Malignant hyperthermia susceptibility 1 (RYR1)
  • Allelic: Malignant hyperthermia susceptibility 5 (CACNA1S)
  • Allelic: Malouf syndrome (LMNA)
  • Allelic: Mandibuloacral dysplasia (LMNA)
  • Allelic: Nemaline myopathy 4, AD (TPM2)
  • Allelic: Orofacial cleft 6 (IRF6)
  • Allelic: Polyglucosan body disease, adult form (GBE1)
  • Allelic: Premature ovarian failure 11 (ERCC6)
  • Allelic: Spinocerebellar ataxia, AR 8 (SYNE1)
  • Allelic: Thyrotoxic periodic paralysis, susceptibility to, 1 (CACNA1S)
  • Allelic: Trichothiodystrophy 1, photosensitive (ERCC2)
  • Allelic: UV-sensitive syndrome 1 (ERCC6)
  • Allelic: Xeroderma pigmentosum, group D (ERCC2)
  • Allelic: van der Woude syndrome (IRF6)
  • Antley-Bixler syndrome without genital anomalies or disordered steroidogenesis (FGFR2)
  • Arthrogryposis [MONDO:0008779; panelapp] (KIF21A)
  • Arthrogryposis [panelapp] (UTRN)
  • Arthrogryposis multiplex congenita 1, neurogenic, with myelin defect (LGI4)
  • Arthrogryposis multiplex congenita 2, neurogenic type (ERGIC1)
  • Arthrogryposis multiplex congenita 6 (NEB)
  • Arthrogryposis multiplex congenita [panelapp] (UNC50)
  • Arthrogryposis multiplex congenita-pulmonary hypoplasia syndrome
  • Arthrogryposis, distal, type 1A (TPM2)
  • Arthrogryposis, distal, type 1B (MYBPC1)
  • Arthrogryposis, distal, type 2A [Freeman-Sheldon] (MYH3)
  • Arthrogryposis, distal, type 2B1 (TNNI2)
  • Arthrogryposis, distal, type 2B2 (TNNT3)
  • Arthrogryposis, distal, type 2B3 [Sheldon-Hall] (MYH3)
  • Arthrogryposis, distal, type 2B4 (TPM2)
  • Arthrogryposis, distal, type 3 (PIEZO2)
  • Arthrogryposis, distal, type 5 (PIEZO2)
  • Arthrogryposis, distal, type 5D (ECEL1)
  • Arthrogryposis, distal, with impaired proprioception + touch (PIEZO2)
  • Arthrogryposis, renal dysfunction, and cholestasis 1 (VPS33B)
  • Arthrogryposis, renal dysfunction, cholestasis 2 (VIPAS39)
  • Cardiomyopathy, dilated, 1A (LMNA)
  • Carney complex variant (MYH8)
  • Central core disease (RYR1)
  • Centronuclear myopathy 1 (DNM2)
  • Centronuclear myopathy 2 (BIN1)
  • Cerebro-oculo-facio-skeletal (COFS) syndrome (ERCC6)
  • Cerebrooculofacioskeletal syndrome 1 (ERCC6)
  • Cerebrooculofacioskeletal syndrome 2 (ERCC2)
  • Cerebrooculofacioskeletal syndrome 4 (ERCC1)
  • Charcot-Marie-Tooth disease, DI B (DNM2)
  • Charcot-Marie-Tooth disease, axonal type 2M (DNM2)
  • Charcot-Marie-Tooth disease, type 2B1 (LMNA)
  • Congenital arthrogryposis with anterior horn cell disease (GLE1)
  • Congenital disorder of glycosylation, type Ij (DPAGT1)
  • Congenital myopathy with excess of muscle spindles (HRAS)
  • Contractures, pterygia + spondylocarpotarsal fusion syndrome 1A (MYH3)
  • Contractures, pterygia + spondylocarpotarsal fusion syndrome 1B (MYH3)
  • Cortical dysplasia, complex, with other brain malformations 7 (TUBB2B)
  • Emery-Dreifuss muscular dystrophy 2, AD (LMNA)
  • Emery-Dreifuss muscular dystrophy 3, AR (LMNA)
  • Escobar syndrome (CHRNG)
  • Fetal akinesia [panelapp] (KIF21A)
  • Fetal akinesia deformation sequence 1 (MUSK)
  • Fetal akinesia deformation sequence 2 (RAPSN)
  • Fetal akinesia deformation sequence 3 (DOK7)
  • Fetal akinesia, growth restriction [panelapp] (CLTC)
  • Glycogen storage disease IV (GBE1)
  • Hyperkalemic periodic paralysis, type 2 (SCN4A)
  • Hypokalemic periodic paralysis, type 1 (CACNA1S)
  • Hypokalemic periodic paralysis, type 2 (SCN4A)
  • Hypomyelinating neuropathy, congenital, 3 (CNTNAP1)
  • King-Denborough syndrome (RYR1)
  • Lethal congenital contracture syndrome 1 (GLE1)
  • Lethal congenital contracture syndrome 2 (ERBB3)
  • Lethal congenital contracture syndrome 3 (PIP5K1C)
  • Lethal congenital contracture syndrome 4 (MYBPC1)
  • Lethal congenital contracture syndrome 5 (DNM2)
  • Lethal congenital contracture syndrome 6 (ZBTB42)
  • Lethal congenital contracture syndrome 7 (CNTNAP1)
  • Lethal congenital contracture syndrome 8 (ADCY6)
  • Lethal congenital contracture syndrome 9 (ADGRG6)
  • Marden-Walker syndrome (PIEZO2)
  • Minicore myopathy with external ophthalmoplegia (RYR1)
  • Multiple pterygium syndrome, lethal type (CHRNA1, CHRND)
  • Multiple pterygium syndrome, lethal type (CHRNG)
  • Muscular dystrophy, congenital (LMNA)
  • Muscular dystrophy, congenital, Davignon-Chauveau type (TRIP4)
  • Muscular dystrophy, limb-girdle, AR (TTN)
  • Muscular dystrophy-dystroglycanopathy (cong. with brain + eye anomalies), type A, 4 (FKTN)
  • Muscular dystrophy-dystroglycanopathy (cong. with brain + eye anomalies), type A, 5 (FKRP)
  • Muscular dystrophy-dystroglycanopathy (cong. with/-out mental retardation), type B, 5 (FKRP)
  • Muscular dystrophy-dystroglycanopathy (cong. without mental retardation), type B, 4 (FKTN)
  • Muscular dystrophy-dystroglycanopathy (limb-girdle), type C, 4 (FKTN)
  • Muscular dystrophy-dystroglycanopathy (limb-girdle), type C, 5 (FKRP)
  • Myasthenic syndrome, congenital, 10 (DOK7)
  • Myasthenic syndrome, congenital, 11, ass. w. acetylcholine receptor deficiency (RAPSN)
  • Myasthenic syndrome, congenital, 13, with tubular aggregates (DPAGT1)
  • Myasthenic syndrome, congenital, 16 (SCN4A)
  • Myasthenic syndrome, congenital, 1A, slow-channel (CHRNA1)
  • Myasthenic syndrome, congenital, 1B, fast-channel (CHRNA1)
  • Myasthenic syndrome, congenital, 21, presynaptic (SLC18A3)
  • Myasthenic syndrome, congenital, 3A, slow-channel (CHRND)
  • Myasthenic syndrome, congenital, 3B, fast-channel (CHRND)
  • Myasthenic syndrome, congenital, 3C, ass. w. acetylcholine receptor deficiency (CHRND)
  • Myasthenic syndrome, congenital, 9, ass. w. acetylcholine receptor deficiency (MUSK)
  • Myopathy, XL, with excessive autophagy (VMA21)
  • Myopathy, actin, congenital, with cores (ACTA1)
  • Myopathy, actin, congenital, with excess of thin myofilaments (ACTA1)
  • Myopathy, centronuclear, XL (MTM1)
  • Myopathy, cong., diaphragmatic defects, respiratory insufficiency, dysmorphic face (MYOD1)
  • Myopathy, congenital, Compton-North (CNTN1)
  • Myopathy, congenital, with fiber-type disproportion 1 (ACTA1)
  • Myopathy, congenital, with tremor (MYBPC1)
  • Myopathy, myofibrillar, 9, with early respiratory failure (TTN)
  • Myopathy, scapulohumeroperoneal (ACTA1)
  • Myotonia congenita, atypical, acetazolamide-responsive (SCN4A)
  • Myotonic dystrophy 1 (DMPK_CTG)
  • Nemaline myopathy 10 (LMOD3)
  • Nemaline myopathy 2, AR (NEB)
  • Nemaline myopathy 3, AD/AR (ACTA1)
  • Nemaline myopathy 8, AR (KLHL40)
  • Nemaline myopathy 9 (KLHL41)
  • Neuromuscular disease, congenital, with uniform type 1 fiber (RYR1)
  • Paramyotonia congenita (SCN4A)
  • Pena Shokeir I/II syndromes
  • Popliteal pterygium syndrome 1 (IRF6)
  • Popliteal pterygium syndrome, Bartsocas-Papas type (RIPK4)
  • Restrictive dermopathy 2 (LMNA)
  • Salih myopathy (TTN)
  • Schaaf-Yang syndrome (MAGEL2)
  • Spinal muscular atrophy with congenital bone fractures 1 (TRIP4)
  • Spinal muscular atrophy with congenital bone fractures 2 (ASCC1)
  • Spinal muscular atrophy, XL 2, infantile (UBA1)
  • Spinal muscular atrophy, lower extremity-predominant, 2A + 2B, AD (BICD2)
  • Spinal muscular atrophy-1, -2, -3, -4 (SMN1)
  • Tibial muscular dystrophy, tardive (TTN)
  • Trismus-pseudocamptodactyly syndrome (MYH8)
  • Visceral neuropathy, familial, 1, AR (ERBB3)
  • Wieacker-Wolff syndrome (ZC4H2)
  • Wieacker-Wolff syndrome, female-restricted (ZC4H2)
Heredity, heredity patterns etc.
  • AD
  • AR
  • XL
OMIM-Ps
  • Multiple OMIM-Ps
ICD10 Code

Bioinformatics and clinical interpretation

Test-Stärken

  • DAkkS-akkreditiertes Labor
  • EU-Richtlinie für IVD in Umsetzung
  • Qualitäts-kontrolliert arbeitendes Personal
  • Leistungsstarke Sequenzierungstechnologien, fortschrittliche Target-Anreicherungsmethoden und Präzisions-Bioinformatik-Pipelines sorgen für überragende analytische Leistung
  • Sorgfältige Kuratierung klinisch relevanter und wissenschaftlich begründeter Gen-Panels
  • eine Vielzahl nicht Protein-kodierender Varianten, die in unseren klinischen NGS-Tests mit erfasst werden
  • unser strenges Variantenklassifizierungsschema nach ACMG-Kriterien
  • unser systematischer klinischer Interpretations-Workflow mit proprietärer Software ermöglicht die genaue und nachvollziehbare Verarbeitung von NGS-Daten
  • unsere umfassenden klinischen Aussagen

Testeinschränkungen

  • Gene mit eingeschränkter Abdeckung werden gekennzeichnet
  • Gene mit kompletten oder partiellen Duplikationen werden gekennzeichnet
  • es wird angenommen, dass ein Gen suboptimal abgedeckt ist, wenn >90% der Nukleotide des Gens bei einem Mapping-Qualitätsfaktor von >20 (MQ>20) nicht abgedeckt sind
  • die Sensitivität der Diagnostik zur Erkennung von Varianten mit genannten Testeinschränkungen ist möglicherweise begrenzt bei:
  • Gen-Konversionen
  • komplexe Inversionen
  • Balancierte Translokationen
  • Mitochondriale Varianten
  • Repeat-Expansionen, sofern nicht anders dokumentiert
  • nicht kodierende Varianten, die Krankheiten verursachen, die von diesem Panel nicht mit abgedeckt werden
  • niedriger Mosaik-Status
  • Repeat-Blöcke von Mononukleotiden
  • Indels >50bp (Insertionen-Deletionen)
  • Deletionen oder Duplikationen einzelner Exons
  • Varianten innerhalb von Pseudogenen
  • die analytische Sensitivität kann geringer ausfallen werden, wenn die DNA nicht von amedes genetics extrahiert wurde

Laboratory requirement

  • Die in grün gezeigten Gene sind kuratiert und werden als Gen-Panel untersucht. Eine Erweiterung des Panels (blau gezeigte Gene, jeweils ebenfalls kuratiert) kann auf Anfrage erfolgen. Sofern unter "Erweitertes Panel" ein Minuszeichen angezeigt wird, sind nur Core-/Basis-Gene verfügbar.

  • Für die Anforderung einer genetischen Untersuchung senden Sie uns bitte die Krankheits-ID auf einem Überweisungsschein. Bitte die Material-Angabe beachten.

  • Für privat versicherte Patienten empfehlen wir einen Antrag auf Kostenübernahme bei der Krankenversicherung.

  • Die Untersuchung wird auch für Selbstzahler angeboten.